| BP-1096 |
|
| (CAS 610798-31-7) |
 |
| Description： |
Icotinib is a potent and specific epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) with an IC(50) of 5 nM, including it's mutants of EGFR(L858R), EGFR(L861Q), EGFR(T790M) and EGFR(T790M, L858R).
in vivo: In vivo studies demonstrated that Icotinib exhibited potent dose-dependent antitumor effects in nude mice carrying a variety of human tumor-derived xenografts. The drug was well tolerated at doses up to 120 mg/kg/day in mice without mortality or significant body weight loss during the treatment. A head to head randomized, double blind phase III trial using Gefitinib as an active control for patients with advanced non-small cell lung cancer (NSCLC) was finished recently (Trial registration ID: NCT01040780) [1]. |
| Product No. |
KT00222 |
| Product Name |
BP-1096 |
| Synonyms |
Icotinib |
| Formal Name |
|
| CAS Number |
610798-31-7 |
| Molecular Formula |
C22H21N3O4 |
| Formula Weight |
391.42 |
| Formulation |
A crystalline solid |
| Purity |
98%min |
| Stability |
2 years |
| Storage |
-20°C |
| Shipping |
USD45 for Europe and USA. No shipping charge once amount reach USD500 |
| Quality Control |
HNMR,CNMR,LCMS,HPLC,IR,etc. |
| Price & Availability |
In Stock. Price Negotiated. |
|
| Related Products： |
AEE788
AG 18
AG-1478
AG-490
ARRY-380
AST-1306
AV-412
AZD-9291
BIBX 1382 |
|
